천공된 세균성 각막염에서 목시플록사신 함유 강화양막이식술의 임상적 적용 2예

Moxifloxacin Mixed Augmented Amniotic Membrane Transplantation for Perforating Infectious Keratitis

Purpose: To report the clinical results of moxifloxacin mixed augmented amniotic membrane transplantation (AMT) in 2 patients with perforating infectious keratitis. Case summary: Moxifloxacin mixed augmented amniotic membrane transplantations were performed in 2 patients with rapidly deteriorating deep perforated bacterial keratitis. All patients preserved their eyesight. Complete re-epithelization over the amniotic membrane were observed within a month. The corneal surfaces were healed with opacity, and there were no active infectious infiltrations or recurrences for 3 months after application. Conclusions: Moxifloxacin mixed augmented AMT has proven to be successful both tectonically and physiologically for cases with perforating active bacterial keratitis. J Korean Ophthalmol Soc 2012;53(2):342-347